Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic D Bushman

Showing results (331-340 of 341) with videos related to

Pageof 35
Sort By:
Science (New York, N.Y.)|February 8, 2020
CRISPR-engineered T cells in patients with refractory cancerEdward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Nature Medicine|March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trialVivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Blood|January 27, 2026
Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory DiarrheaViktoria Blumenberg, Filippo Birocchi, Angela Shih, et al.
Nature Microbiology|March 31, 2025
Gut metagenomes reveal interactions between dietary restriction, ageing and the microbiome in genetically diverse miceLev Litichevskiy, Maya Considine, Jasleen Gill, et al.
Science Advances|November 13, 2024
TET2 regulates early and late transitions in exhausted CD8<sup>+</sup> T cell differentiation and limits CAR T cell functionAlexander J Dimitri, Amy E Baxter, Gregory M Chen, et al.
The New England Journal of Medicine|October 9, 2014
A modified γ-retrovirus vector for X-linked severe combined immunodeficiencySalima Hacein-Bey-Abina, Sung-Yun Pai, H Bobby Gaspar, et al.
Blood|July 21, 2023
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndromeRoxane Labrosse, Julia I Chu, Myriam A Armant, et al.
Nature|January 25, 2023
Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studiesKatherine M Kennedy, Marcus C de Goffau, Maria Elisa Perez-Muñoz, et al.
Nature Medicine|January 15, 2026
CD4<sup>+</sup> T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapyMatthew Ho, Luca Paruzzo, Julia Han Noll, et al.
Nature Medicine|January 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapiesJulie K Jadlowsky, Elizabeth O Hexner, Amy Marshall, et al.
Pageof 35

Showing results (331-340 of 341) with videos related to

Sort By:
Pageof 35
Science (New York, N.Y.)|February 8, 2020
CRISPR-engineered T cells in patients with refractory cancerEdward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Nature Medicine|March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trialVivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Blood|January 27, 2026
Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory DiarrheaViktoria Blumenberg, Filippo Birocchi, Angela Shih, et al.
Nature Microbiology|March 31, 2025
Gut metagenomes reveal interactions between dietary restriction, ageing and the microbiome in genetically diverse miceLev Litichevskiy, Maya Considine, Jasleen Gill, et al.
Science Advances|November 13, 2024
TET2 regulates early and late transitions in exhausted CD8<sup>+</sup> T cell differentiation and limits CAR T cell functionAlexander J Dimitri, Amy E Baxter, Gregory M Chen, et al.
The New England Journal of Medicine|October 9, 2014
A modified γ-retrovirus vector for X-linked severe combined immunodeficiencySalima Hacein-Bey-Abina, Sung-Yun Pai, H Bobby Gaspar, et al.
Blood|July 21, 2023
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndromeRoxane Labrosse, Julia I Chu, Myriam A Armant, et al.
Nature|January 25, 2023
Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studiesKatherine M Kennedy, Marcus C de Goffau, Maria Elisa Perez-Muñoz, et al.
Nature Medicine|January 15, 2026
CD4<sup>+</sup> T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapyMatthew Ho, Luca Paruzzo, Julia Han Noll, et al.
Nature Medicine|January 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapiesJulie K Jadlowsky, Elizabeth O Hexner, Amy Marshall, et al.
Pageof 35